Omeros Corp. Stock
Price
Target price
€8.24
€8.24
-1.200%
-0.1
-1.200%
€30.91
10.06.26 / Frankfurt
WKN: A0NBFF / Symbol: OMER / Name: Omeros / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Omeros Corp. Stock
We can see a decrease in the price for Omeros Corp.. Compared to yesterday it has lost -€0.100 (-1.200%).
With 20 Buy predictions and not the single Sell prediction the community is currently very high on Omeros Corp..
With a target price of 30 € there is potential for a 264.08% increase which would mean more than doubling the current price of 8.24 € for Omeros Corp..
Our community identified positive and negative aspects for Omeros Corp. stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Omeros Corp. stock. On the other hand our users think that "Non-cyclic/Cyclic" could be a problem in the future.
Pros and Cons of Omeros Corp. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Omeros Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Omeros Corp. | -1.200% | -4.850% | -32.459% | 148.193% | -38.963% | 18.221% | -36.346% |
| Heron Therapeutics Inc. | 5.540% | -7.752% | -65.640% | -80.843% | -68.169% | -69.431% | -97.164% |
| Evolus Inc | -2.320% | 9.624% | 5.568% | -33.529% | 3.670% | -26.144% | -36.872% |
| Rhythm Pharmaceuticals | -1.320% | 2.740% | -6.250% | 30.435% | -19.786% | 368.750% | 390.196% |
Comments
Omeros (OMER) had its "buy" rating reaffirmed by HC Wainwright. They now have a $40.00 price target on the stock.
Show more
Ratings data for OMER provided by MarketBeat
Omeros (OMER) had its "buy" rating reaffirmed by HC Wainwright. They now have a $40.00 price target on the stock.
Show more
Ratings data for OMER provided by MarketBeat
Omeros (OMER) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $36.00 price target on the stock.
Show more
Ratings data for OMER provided by MarketBeat
News
Omeros Q1 Earnings Call Highlights
Omeros (NASDAQ:OMER) reported first-quarter 2026 net income of $56.1 million, or $0.78 per share, as the company began commercial sales of YARTEMLEA
Why Omeros Stock Skyrocketed Today
For the most part, the stock market tends to be sedate in the late holiday season. That sure wasn't the case on Wednesday with Omeros (NASDAQ: OMER), which saw a nearly 76% share price leap after
